Purpose Dosimetric accuracy is critical when switching a patient treated with stereotactic body radiation therapy (SBRT) or stereotactic fractionated radiotherapy (SRT) among beam‐matched linacs. In this study, the dose delivery accuracy of volumetric modulated arc therapy (VMAT) plans for SBRT/SRT patients were evaluated on three beam‐matched linacs. Method Beam data measurements such as percentage depth dose (PDD10), beam profiles, output factors, and multi‐leaf collimator (MLC) leaf transmission factor for 6 MV photon beam were performed on three beam‐matched linacs. The Edge™ diode detector was used for measurements of beams of field size less than 5 × 5 cm2. Ten lung and 15 brain plans were generated using VMAT with the same beam model. Modulation complexity score of the VMAT plan (MCSv) was used as a plan complexity indicator. Doses were measured using ArcCHECK™ and GafChromic™ EBT3 films. The measurements were compared with calculated doses through absolute dose gamma comparison using 3%/2 mm and 2%/2 mm criteria. Correlation between difference in passing rates among beam‐matched linacs and MCSv was evaluated using the Pearson coefficient. Point doses were measured with the A1SL micro ion chamber. Results Difference in beam outputs, beam profiles, and MLC leaf transmission factors of beam‐matched linacs were all within ±1%, except the difference in output factor for 1 × 1 cm2 field between linac 1 and 3 (1.3%). For all 25 cases, passing rates of measured doses on three linacs were all higher than 90% when using 2%/2 mm gamma criteria. The average difference in point dose measurements among three beam‐matched linacs was 0.1 ± 0.2% (P > 0.05, one‐way ANOVA). Conclusion Minimal differences in beam parameters, point doses, and passing rates among three linacs proved the viability of swapping SBRT/SRT using VMAT among beam‐matched linacs. The effect of plan complexity on passing rate difference among beam‐matched linacs is not statistically significant.
Purpose: Stereotactic core ablative radiation therapy (SCART) delivers a single ablative dose core to the central hypoxic part while keeping low doses to the periphery of the tumor. This study evaluated the dosimetric impacts of various SCART planning approaches for small targets in the context of spatially fractionated radiation therapy (SFRT).Methods and materials: Using an anthropomorphic phantom, SCART plans were generated for cases with one spherical target, two spherical targets, one spherical target and one irregularly shaped target, and four spherical targets. All the spherical targets were 3 cm in diameter. One-third of the central gross target volume (GTV) was contoured as GTV_central to represent the hypoxic tumor volume, while the rest was contoured as GTV_peripheral for low-dose (3-Gy) coverage. Within each GTV, a small sphere with a diameter ranging from 0.5 to 1.5 cm was contoured at the center to represent the volume of a single high-dose core (V_SHDC). For the irregularly shaped target, both spherical (V_SHDC) and conformal (V_cSHDC) high-dose cores were used for comparisons. A single fraction of 15 Gy was prescribed to V_SHDC in all plans. Single- and dual-isocenter techniques were used for the case of two targets. Dosimetric parameters, which were usually used to describe SFRT plans, were compared for all SCART plans. The pros and cons of all planning approaches were elaborated.Results: The mean dose to V_SHDC was 17.0 ± 0.7 Gy. For multiple-target SCART plans, the peripheral GTV receiving less than 3 Gy (VGTVp<3Gy) ranged from 35.1% to 63.6%. No significant difference in dosimetric parameters was found between plans using a single isocenter and dual isocenters. For the irregularly shaped target, V_cSHDC improved the equivalent uniform dose (EUD) while the low-dose (3-Gy) coverage (VGTVp<3Gy) decreased. The average D10/D90 of all the plans was 8.0 ± 1.7. SCART used 1-cm-diameter V_SHDC (volume ratio of V_SHDC/GTV was within 2%–5%), demonstrating better dosimetric balance between high-dose coverage for GTV_central and low-dose coverage for GTV_peripheral.Conclusion: SCART for small targets is feasible; the plans demonstrated a comparable dosimetric quality as seen in the traditional SFRT plans for bulky tumors.
Purpose: The purpose of this study is to characterize the dosimetric properties of a commercial brass GRID collimator for high energy photon beams including 15 and 10 MV. Then, the difference in dosimetric parameters of GRID beams among different energies and linacs was evaluated.Method: A water tank scanning system was used to acquire the dosimetric parameters, including the percentage depth dose (PDD), beam profiles, peak to valley dose ratios (PVDRs), and output factors (OFs). The profiles at various depths were measured at 100 cm source to surface distance (SSD), and field sizes of 10 × 10 cm2 and 20 × 20 cm2 on three linacs. The PVDRs and OFs were measured and compared with the treatment planning system (TPS) calculations.Results: Compared with the open beam data, there were noticeable changes in PDDs of GRID fields across all the energies. The GRID fields demonstrated a maximal of 3 mm shift in dmax (Truebeam STX, 15MV, 10 × 10 cm2). The PVDR decreased as beam energy increases. The difference in PVDRs between Trilogy and Truebeam STx using 6MV and 15MV was 1.5% ± 4.0% and 2.1% ± 4.3%, respectively. However, two Truebeam linacs demonstrated less than 2% difference in PVDRs. The OF of the GRID field was dependent on the energy and field size. The measured PDDs, PVDRs, and OFs agreed with the TPS calculations within 3% difference. The TPS calculations agreed with the measurements when using 1 mm calculation resolution.Conclusion: The dosimetric characteristics of high‐energy GRID fields, especially PVDR, significantly differ from those of low‐energy GRID fields. Two Truebeam machines are interchangeable for GRID therapy, while a pronounced difference was observed between Truebeam and Trilogy. A series of empirical equations and reference look‐up tables for GRID therapy can be generated to facilitate clinical applications.